Toinv,

The subgroup analysis found for the eGFR<60 vs. eGFR>60 an unadjusted p-value of 0.032.

Now, this is where I get lost. Is this p=0.032 for:

1) placebo vs. apabetalone in those patients with eGFR<60

or 2) A comparison of the RRR/hazard ratio between eGFR<60 and eGFR>60 patients to simply prove that there is an eGFR interaction?

BDAZ